Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response

Mostrar otras versiones (1)

Understanding the molecular features of neutralizing epitopes is important for developing vaccines/therapeutics against emerging SARS-CoV-2 variants. We describe three monoclonal antibodies (mAbs) generated from COVID-19 recovered individuals during the first wave of the pandemic in India. These mAb...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Anamika, Kumar, Sanjeev, Lai, Lilin, Chakravarthy, Chennareddy, Valanparambil, Rajesh, Reddy, Elluri Seetharami, Gottimukkala, Kamalvishnu, Bajpai, Prashant, Raju, Dinesh Ravindra, Edara, Venkata Viswanadh, Davis-Gardner, Meredith E., Linderman, Susanne, Dixit, Kritika, Sharma, Pragati, Mantus, Grace, Cheedarla, Narayanaiah, Verkerke, Hans P., Frank, Filipp, Neish, Andrew S., Roback, John D., Davis, Carl W., Wrammert, Jens, Ahmed, Rafi, Suthar, Mehul S., Sharma, Amit, Murali-Krishna, Kaja, Chandele, Anmol, Ortlund, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171968/
https://www.ncbi.nlm.nih.gov/pubmed/37167972
http://dx.doi.org/10.1016/j.str.2023.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171968/
https://www.ncbi.nlm.nih.gov/pubmed/37167972
http://dx.doi.org/10.1016/j.str.2023.04.010

Ejemplares similares